Press Release: Abacus dx Announces Partnership with Inpeco
Abacus dx Announces Distribution Partnership with Inpeco in Australia
Brisbane, Australia – February 17, 2025
Abacus dx Announces Distribution Partnership with Inpeco in Australia
Brisbane, Australia – February 17, 2025
Abacus dx Announces Commercial Partnership with Response Biomedical in Australia & New Zealand’s Clinical Market Sector
Brisbane, 6th November 2024
Abacus dx Announces Commercial Partnership with Epredia in Australia & New Zealand’s Clinical Market Sector
Brisbane, 1st July 2024
Abacus dx Announces Commercial Partnership with Roche in Australia’s Life Science sector
Brisbane, 1st June 2024
Products are for professional/laboratory use only.
Abacus dx Pty Ltd Announces Partnership with Nikon Microscopes for Australia & New Zealand Pathology Markets
Brisbane, 11th August 2023
Abacus dx are pleased to announce our sponsored speaker session at ASCIA will be held on Wednesday 31 August at 8:10am via a virtual presentation.
Products are for professional/laboratory use only.
In the light of the rapidly developing COVID-19 pandemic, we would like to provide the following information about the steps Abacus dx has taken in response to the virus outbreak:
Products are for professional/laboratory use only.
Abacus ALS & Diagnostic Solutions are now Abacus dx
Brisbane, November 21, 2017, Abacus ALS Pty Ltd (Abacus ALS) and Diagnostic Solutions Pty Ltd (Diagnostic Solutions) today announced
Products are for professional/laboratory use only.
In recent times the shareholders of Abacus ALS have been exploring options to transition away from the current shareholding of the business. We are pleased to announce that Diploma PLC has acquired Abacus ALS, and the company will be included in the Diploma Healthcare Group.